Cargando…

Adverse event following vaccine surveillance in Kaduna State, Northwestern Nigeria (January 2018 -June 2019): analysis of health facility´s records

INTRODUCTION: Adverse Events Following Immunization (AEFI) are one of the main reasons for inadequate immunization coverage in Kaduna State, and AEFI underreporting serves as a barrier to achieving goals of global pharmaco-vigilance for vaccine. The purpose of this study is to estimate the completen...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishaku, Sambo Godwin, Umeh, Gregory, Adzu, Bulus, Onimisi, Anthony, Dauda, Madubu, Iyal, Hadiza Aliyu, Iliyasu, Neyu, Sunday, Danjuma Jenom, Daikwo, Jeremiah, Yates, Sannom Mildred, Ibrahim, Ibrahim Idris, Samaila, Lami Hajara, Abdullahi, Basirat, Parom, Stephen Kadarko, Maiwashi, Kabir Yusuf, Zakari, Fureratu, Nuhu, Kase Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The African Field Epidemiology Network 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856967/
https://www.ncbi.nlm.nih.gov/pubmed/35251462
http://dx.doi.org/10.11604/pamj.2021.40.268.26961
_version_ 1784653955062562816
author Ishaku, Sambo Godwin
Umeh, Gregory
Adzu, Bulus
Onimisi, Anthony
Dauda, Madubu
Iyal, Hadiza Aliyu
Iliyasu, Neyu
Sunday, Danjuma Jenom
Daikwo, Jeremiah
Yates, Sannom Mildred
Ibrahim, Ibrahim Idris
Samaila, Lami Hajara
Abdullahi, Basirat
Parom, Stephen Kadarko
Maiwashi, Kabir Yusuf
Zakari, Fureratu
Nuhu, Kase Sarah
author_facet Ishaku, Sambo Godwin
Umeh, Gregory
Adzu, Bulus
Onimisi, Anthony
Dauda, Madubu
Iyal, Hadiza Aliyu
Iliyasu, Neyu
Sunday, Danjuma Jenom
Daikwo, Jeremiah
Yates, Sannom Mildred
Ibrahim, Ibrahim Idris
Samaila, Lami Hajara
Abdullahi, Basirat
Parom, Stephen Kadarko
Maiwashi, Kabir Yusuf
Zakari, Fureratu
Nuhu, Kase Sarah
author_sort Ishaku, Sambo Godwin
collection PubMed
description INTRODUCTION: Adverse Events Following Immunization (AEFI) are one of the main reasons for inadequate immunization coverage in Kaduna State, and AEFI underreporting serves as a barrier to achieving goals of global pharmaco-vigilance for vaccine. The purpose of this study is to estimate the completeness of variables in the AEFI line-listing forms, calculate AEFI reporting rates by Local Government Areas & vaccine type and profile the reported cases according to their reactions. METHODS: we conducted a descriptive, cross-sectional, retrospective study of primary surveillance records. We calculated AEFI reporting rates in the State and Local Government areas and AEFI Vaccine reaction rates to the various antigens. We used Binary logistic regression to determine the association between gender and vaccine reactions. RESULTS: seven thousand eight hundred and twenty-four (7,824) AEFI cases were reported. The completeness of variables on the filled AEFI line-list varied from 21% to 100%. The State had a high AEFI reporting rate of 9.09 per 10,000 administered doses. Fever (<38oC) was the main AEFI reaction. Severe AEFI cases accounted for only 0.89% of the total reported cases. Pentavalent vaccine was the suspect antigen responsible for the highest number of AEFI cases, with a vaccine reaction rate of 44.77 per 10,000 doses. The Zaria Local Government area had the highest AEFI reporting rate, while the Sanga Local Government area had the lowest AEFI reporting rate in the State. The difference between genders in the number of reported AEFI cases was not statistically significant (p>0.05). There were 35% higher odds of occurrence of bleeding among males than among females (aOR: 1.354; P-value: p=.012; 95% CI: 1.070-1.715; Nagelkerke-R(2-): 0.003). The other reactions were not significantly related to gender. CONCLUSION: our study shows a higher occurrence of severe AEFI in subjects undergoing pentavalent vaccine. Thiscaused the highest incidence of AEFI. There was no significant association between gender and AEFI reactions.
format Online
Article
Text
id pubmed-8856967
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The African Field Epidemiology Network
record_format MEDLINE/PubMed
spelling pubmed-88569672022-03-04 Adverse event following vaccine surveillance in Kaduna State, Northwestern Nigeria (January 2018 -June 2019): analysis of health facility´s records Ishaku, Sambo Godwin Umeh, Gregory Adzu, Bulus Onimisi, Anthony Dauda, Madubu Iyal, Hadiza Aliyu Iliyasu, Neyu Sunday, Danjuma Jenom Daikwo, Jeremiah Yates, Sannom Mildred Ibrahim, Ibrahim Idris Samaila, Lami Hajara Abdullahi, Basirat Parom, Stephen Kadarko Maiwashi, Kabir Yusuf Zakari, Fureratu Nuhu, Kase Sarah Pan Afr Med J Research INTRODUCTION: Adverse Events Following Immunization (AEFI) are one of the main reasons for inadequate immunization coverage in Kaduna State, and AEFI underreporting serves as a barrier to achieving goals of global pharmaco-vigilance for vaccine. The purpose of this study is to estimate the completeness of variables in the AEFI line-listing forms, calculate AEFI reporting rates by Local Government Areas & vaccine type and profile the reported cases according to their reactions. METHODS: we conducted a descriptive, cross-sectional, retrospective study of primary surveillance records. We calculated AEFI reporting rates in the State and Local Government areas and AEFI Vaccine reaction rates to the various antigens. We used Binary logistic regression to determine the association between gender and vaccine reactions. RESULTS: seven thousand eight hundred and twenty-four (7,824) AEFI cases were reported. The completeness of variables on the filled AEFI line-list varied from 21% to 100%. The State had a high AEFI reporting rate of 9.09 per 10,000 administered doses. Fever (<38oC) was the main AEFI reaction. Severe AEFI cases accounted for only 0.89% of the total reported cases. Pentavalent vaccine was the suspect antigen responsible for the highest number of AEFI cases, with a vaccine reaction rate of 44.77 per 10,000 doses. The Zaria Local Government area had the highest AEFI reporting rate, while the Sanga Local Government area had the lowest AEFI reporting rate in the State. The difference between genders in the number of reported AEFI cases was not statistically significant (p>0.05). There were 35% higher odds of occurrence of bleeding among males than among females (aOR: 1.354; P-value: p=.012; 95% CI: 1.070-1.715; Nagelkerke-R(2-): 0.003). The other reactions were not significantly related to gender. CONCLUSION: our study shows a higher occurrence of severe AEFI in subjects undergoing pentavalent vaccine. Thiscaused the highest incidence of AEFI. There was no significant association between gender and AEFI reactions. The African Field Epidemiology Network 2021-12-30 /pmc/articles/PMC8856967/ /pubmed/35251462 http://dx.doi.org/10.11604/pamj.2021.40.268.26961 Text en Copyright: Sambo Godwin Ishaku et al. https://creativecommons.org/licenses/by/4.0/The Pan African Medical Journal (ISSN: 1937-8688). This is an Open Access article distributed under the terms of the Creative Commons Attribution International 4.0 License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Ishaku, Sambo Godwin
Umeh, Gregory
Adzu, Bulus
Onimisi, Anthony
Dauda, Madubu
Iyal, Hadiza Aliyu
Iliyasu, Neyu
Sunday, Danjuma Jenom
Daikwo, Jeremiah
Yates, Sannom Mildred
Ibrahim, Ibrahim Idris
Samaila, Lami Hajara
Abdullahi, Basirat
Parom, Stephen Kadarko
Maiwashi, Kabir Yusuf
Zakari, Fureratu
Nuhu, Kase Sarah
Adverse event following vaccine surveillance in Kaduna State, Northwestern Nigeria (January 2018 -June 2019): analysis of health facility´s records
title Adverse event following vaccine surveillance in Kaduna State, Northwestern Nigeria (January 2018 -June 2019): analysis of health facility´s records
title_full Adverse event following vaccine surveillance in Kaduna State, Northwestern Nigeria (January 2018 -June 2019): analysis of health facility´s records
title_fullStr Adverse event following vaccine surveillance in Kaduna State, Northwestern Nigeria (January 2018 -June 2019): analysis of health facility´s records
title_full_unstemmed Adverse event following vaccine surveillance in Kaduna State, Northwestern Nigeria (January 2018 -June 2019): analysis of health facility´s records
title_short Adverse event following vaccine surveillance in Kaduna State, Northwestern Nigeria (January 2018 -June 2019): analysis of health facility´s records
title_sort adverse event following vaccine surveillance in kaduna state, northwestern nigeria (january 2018 -june 2019): analysis of health facility´s records
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856967/
https://www.ncbi.nlm.nih.gov/pubmed/35251462
http://dx.doi.org/10.11604/pamj.2021.40.268.26961
work_keys_str_mv AT ishakusambogodwin adverseeventfollowingvaccinesurveillanceinkadunastatenorthwesternnigeriajanuary2018june2019analysisofhealthfacilitysrecords
AT umehgregory adverseeventfollowingvaccinesurveillanceinkadunastatenorthwesternnigeriajanuary2018june2019analysisofhealthfacilitysrecords
AT adzubulus adverseeventfollowingvaccinesurveillanceinkadunastatenorthwesternnigeriajanuary2018june2019analysisofhealthfacilitysrecords
AT onimisianthony adverseeventfollowingvaccinesurveillanceinkadunastatenorthwesternnigeriajanuary2018june2019analysisofhealthfacilitysrecords
AT daudamadubu adverseeventfollowingvaccinesurveillanceinkadunastatenorthwesternnigeriajanuary2018june2019analysisofhealthfacilitysrecords
AT iyalhadizaaliyu adverseeventfollowingvaccinesurveillanceinkadunastatenorthwesternnigeriajanuary2018june2019analysisofhealthfacilitysrecords
AT iliyasuneyu adverseeventfollowingvaccinesurveillanceinkadunastatenorthwesternnigeriajanuary2018june2019analysisofhealthfacilitysrecords
AT sundaydanjumajenom adverseeventfollowingvaccinesurveillanceinkadunastatenorthwesternnigeriajanuary2018june2019analysisofhealthfacilitysrecords
AT daikwojeremiah adverseeventfollowingvaccinesurveillanceinkadunastatenorthwesternnigeriajanuary2018june2019analysisofhealthfacilitysrecords
AT yatessannommildred adverseeventfollowingvaccinesurveillanceinkadunastatenorthwesternnigeriajanuary2018june2019analysisofhealthfacilitysrecords
AT ibrahimibrahimidris adverseeventfollowingvaccinesurveillanceinkadunastatenorthwesternnigeriajanuary2018june2019analysisofhealthfacilitysrecords
AT samailalamihajara adverseeventfollowingvaccinesurveillanceinkadunastatenorthwesternnigeriajanuary2018june2019analysisofhealthfacilitysrecords
AT abdullahibasirat adverseeventfollowingvaccinesurveillanceinkadunastatenorthwesternnigeriajanuary2018june2019analysisofhealthfacilitysrecords
AT paromstephenkadarko adverseeventfollowingvaccinesurveillanceinkadunastatenorthwesternnigeriajanuary2018june2019analysisofhealthfacilitysrecords
AT maiwashikabiryusuf adverseeventfollowingvaccinesurveillanceinkadunastatenorthwesternnigeriajanuary2018june2019analysisofhealthfacilitysrecords
AT zakarifureratu adverseeventfollowingvaccinesurveillanceinkadunastatenorthwesternnigeriajanuary2018june2019analysisofhealthfacilitysrecords
AT nuhukasesarah adverseeventfollowingvaccinesurveillanceinkadunastatenorthwesternnigeriajanuary2018june2019analysisofhealthfacilitysrecords